Showing results for Aging

IU School of Medicine researchers aim to develop a new treatment for neurodegeneration by targeting an immune cell-specific gene associated with Alzheimer's disease.

IU School of Medicine researchers have identified a portfolio of novel drug targets that may accelerate promising treatments for people living with Alzheimer’s disease.

Researchers have identified a new genetic marker that could play a role in the development of Alzheimer's disease and pave the way for novel therapeutic ...

With many types of at-home medical tests now available on store shelves and websites, a new study looks at what older adults think about this ...

IU School of Medicine researchers have uncovered key mechanisms that may protect against cognitive decline in Alzheimer's disease by studying the brains of people who, ...

Two new papers published in Alzheimer's & Dementia demonstrate that evaluating microRNAs in blood can be used not only to diagnose mild cognitive impairment (MCI) ...

IU School of Medicine researchers have cumulatively been awarded grant funding through the U.S. Department of Veterans Affairs to support research on diabetes, skin inflammation, ...

Pulling on a white lab coat and protective gloves, Bill Gates was ready to get a hands-on feel for some of the most leading-edge Alzheimer’s ...

New drugs have emerged that can slow the cognitive decline from Alzheimer's disease. IU School of Medicine researchers have been at the forefront of this ...

The largest study of early-onset Alzheimer's disease in the United States, headquartered at the Indiana University School of Medicine, is growing to include five new ...